Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth

Daniel E Roth, Shaun K Morris, Stanley Zlotkin, Alison D Gernand, Tahmeed Ahmed, Shaila S Shanta, Eszter Papp, Jill Korsiak, Joy Shi, M Munirul Islam, Ishrat Jahan, Farhana K Keya, Andrew R Willan, Rosanna Weksberg, Minhazul Mohsin, Qazi S Rahman, Prakesh S Shah, Kellie E Murphy, Jennifer Stimec, Lisa G Pell, Huma Qamar, Abdullah Al Mahmud, Daniel E Roth, Shaun K Morris, Stanley Zlotkin, Alison D Gernand, Tahmeed Ahmed, Shaila S Shanta, Eszter Papp, Jill Korsiak, Joy Shi, M Munirul Islam, Ishrat Jahan, Farhana K Keya, Andrew R Willan, Rosanna Weksberg, Minhazul Mohsin, Qazi S Rahman, Prakesh S Shah, Kellie E Murphy, Jennifer Stimec, Lisa G Pell, Huma Qamar, Abdullah Al Mahmud

Abstract

Background: It is unclear whether maternal vitamin D supplementation during pregnancy and lactation improves fetal and infant growth in regions where vitamin D deficiency is common.

Methods: We conducted a randomized, double-blind, placebo-controlled trial in Bangladesh to assess the effects of weekly prenatal vitamin D supplementation (from 17 to 24 weeks of gestation until birth) and postpartum vitamin D supplementation on the primary outcome of infants' length-for-age z scores at 1 year according to World Health Organization (WHO) child growth standards. One group received neither prenatal nor postpartum vitamin D (placebo group). Three groups received prenatal supplementation only, in doses of 4200 IU (prenatal 4200 group), 16,800 IU (prenatal 16,800 group), and 28,000 IU (prenatal 28,000 group). The fifth group received prenatal supplementation as well as 26 weeks of postpartum supplementation in the amount of 28,000 IU (prenatal and postpartum 28,000 group).

Results: Among 1164 infants assessed at 1 year of age (89.5% of 1300 pregnancies), there were no significant differences across groups in the mean (±SD) length-for-age z scores. Scores were as follows: placebo, -0.93±1.05; prenatal 4200, -1.11±1.12; prenatal 16,800, -0.97±0.97; prenatal 28,000, -1.06±1.07; and prenatal and postpartum 28,000, -0.94±1.00 (P=0.23 for a global test of differences across groups). Other anthropometric measures, birth outcomes, and morbidity did not differ significantly across groups. Vitamin D supplementation had expected effects on maternal and infant serum 25-hydroxyvitamin D and calcium concentrations, maternal urinary calcium excretion, and maternal parathyroid hormone concentrations. There were no significant differences in the frequencies of adverse events across groups, with the exception of a higher rate of possible hypercalciuria among the women receiving the highest dose.

Conclusions: In a population with widespread prenatal vitamin D deficiency and fetal and infant growth restriction, maternal vitamin D supplementation from midpregnancy until birth or until 6 months post partum did not improve fetal or infant growth. (Funded by the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, NCT01924013 .).

Figures

Figure 1: Trial flow diagram
Figure 1: Trial flow diagram
Figure 2: Study design and CONSORT diagram
Figure 2: Study design and CONSORT diagram
Maternal, venous cord, and infant 25-hydroxyvitamin D (25(OH)D) [nmol/L], and maternal iPTH [pmol/L] concentrations, by vitamin D supplementation group. (A) Mean maternal 25(OH)D at baseline (n=1285), delivery (n=656; delivery specimens were collected within -19 days to 11 days of delivery [median: 0 days]), 3 months postpartum (n=581), and 6 months postpartum (n=590). Bars denote 95% confidence intervals (CI); (B) Mean 25(OH)D concentrations in venous cord (n=507), infants at 3 months (n=345), infants at 6 months (n=254), and infants at 12 months (n=182). Bars denote 95% CI; (C) Geometric means of maternal iPTH concentrations [pmol/L] at baseline (n=608), delivery (n=551; delivery specimens were collected within -19 days to 11 days of delivery [median: 0 days]), and 6 months postpartum (n=588). Bars denote 95% CI.

References

    1. Danaei G, Andrews KG, Sudfeld CR, Fink G, McCoy DC, Peet E, et al. Risk Factors for Childhood Stunting in 137 Developing Countries: A Comparative Risk Assessment Analysis at Global, Regional, and Country Levels. PLoS Med 2016; 13: e1002164.
    1. Woo Baidal JA, Locks LM, Cheng ER, Blake-Lamb TL, Perkins ME, Taveras EM. Risk Factors for Childhood Obesity in the First 1,000 Days: A Systematic Review. Am J Prev Med 2016; 50: 761-79.
    1. Devakumar D, Fall CH, Sachdev HS, Margetts BM, Osmond C, Wells JC, et al. Maternal antenatal multiple micronutrient supplementation for long-term health benefits in children: a systematic review and meta-analysis. BMC medicine 2016; 14: 90.
    1. Lee AC, Kozuki N, Cousens S, Stevens GA, Blencowe H, Silveira MF, et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ 2017; 358: j3677.
    1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382: 427-51.
    1. Christakos S. Mechanism of action of 1,25-dihydroxyvitamin D3 on intestinal calcium absorption. Rev Endocr Metab Disord 2012; 13: 39-44.
    1. Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol 2011; 22: 216-24.
    1. Lederer E. Regulation of serum phosphate. J Physiol 2014; 592: 3985-95.
    1. Eisman JA, Bouillon R. Vitamin D: direct effects of vitamin D metabolites on bone: lessons from genetically modified mice. Bonekey Rep 2014; 3: 499.
    1. St-Arnaud R, Naja RP. Vitamin D metabolism, cartilage and bone fracture repair. Mol Cell Endocrinol 2011; 347: 48-54.
    1. Ciresi A, Giordano C. Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess. Growth Horm IGF Res 2017; 33: 35-42.
    1. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013; 346.
    1. Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials. BMJ 2017; 359: j5237.
    1. Roth DE, Perumal N, Al Mahmud A, Baqui AH. Maternal vitamin D3 supplementation during the third trimester of pregnancy: effects on infant growth in a longitudinal follow-up study in Bangladesh. J Pediatr 2013; 163: 1605-11 e3.
    1. Research NIoP, Training - NIPORT/Bangladesh, Mitra, Associates, ICF International. Bangladesh Demographic and Health Survey 2014. Dhaka, Bangladesh: NIPORT, Mitra and Associates, and ICF International, 2016.
    1. icddr,b, UNICEF, Bangladesh GAIN, Institute of Public Health and Nutrition. National Micronutrients Status Survey 2011-12. Dhaka, Bangladesh: icddr,b and UNICEF, Bangladesh, 2013.
    1. Roth DE, Gernand AD, Morris SK, Pezzack B, Islam MM, Dimitris MC, et al. Maternal vitamin D supplementation during pregnancy and lactation to promote infant growth in Dhaka, Bangladesh (MDIG trial): study protocol for a randomized controlled trial. Trials 2015; 16: 300.
    1. Cheikh Ismail L, Knight HE, Bhutta Z, Chumlea WC, International F, Newborn Growth Consortium for the 21st C. Anthropometric protocols for the construction of new international fetal and newborn growth standards: the INTERGROWTH-21st Project. BJOG 2013; 120 Suppl 2: 42-7, v.
    1. Shi J, Korsiak J, Roth DE. New approach for the identification of implausible values and outliers in longitudinal childhood anthropometric data. Annals of Epidemiology 2018; 28: 204-11.e3.
    1. Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 2014; 384: 857-68.
    1. Villar J, Giuliani F, Bhutta ZA, Bertino E, Ohuma EO, Ismail LC, et al. Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21(st) Project. Lancet Glob Health 2015; 3: e681-91.
    1. World Health Organization Child Growth Standards. Available from: .
    1. Seamans KM, Cashman KD. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009; 89: 1997S-2008.
    1. Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2010.
    1. Gordon AY, Salzman P. Optimality of the Holm procedure among general step-down multiple testing procedures. Statistics & Probability Letters 2008; 78: 1878-84.
    1. Cooper C, Harvey NC, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, et al. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. The lancet Diabetes & endocrinology 2016; 4: 393-402.
    1. Litonjua AA, Carey VJ, Laranjo N, Harshfield BJ, McElrath TF, O'Connor GT, et al. Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The VDAART Randomized Clinical Trial. JAMA 2016; 315: 362- 70.
    1. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: Double blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26: 2341-57.
    1. Grant CC, Stewart AW, Scragg R, Milne T, Rowden J, Ekeroma A, et al. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration. Pediatrics 2014; 133: e143-53.
    1. Brooke OG, Butters F, Wood C. Intrauterine vitamin D nutrition and postnatal growth in Asian infants. Br Med J (Clin Res Ed) 1981; 283: 1024.
    1. Wagner CL, Hollis BW, Kotsa K, Fakhoury H, Karras SN. Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. Reviews in Endocrine and Metabolic Disorders 2017; 18: 307-22.
    1. Chawes BL, Bønnelykke K, Stokholm J, et al. Effect of vitamin d3 supplementation during pregnancy on risk of persistent wheeze in the offspring: A randomized clinical trial. JAMA 2016; 315: 353-61.
    1. Morris SK, Pell LG, Rahman MZ, Dimitris MC, Mahmud A, Islam MM, et al. Maternal vitamin D supplementation during pregnancy and lactation to prevent acute respiratory infections in infancy in Dhaka, Bangladesh (MDARI trial): protocol for a prospective cohort study nested within a randomized controlled trial. BMC Pregnancy Childbirth 2016; 16: 309.
    1. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organization; 2016. p. 152 pages.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera